@misc{misc, title = {{The cost-effectiveness of expanding the NHS newborn bloodspot screening programme to include homocystinuria (HCU), maple syrup urine disease (MSUD), glutaric aciduria type 1 (GA1), isovaleric acidaemia (IVA), and long-chain hydroxyl acyl-CoA dehydrogenase deficiency (LCHADD) (2014)}}, url = {{}}, year = {{-0001}}, month = {{11}}, author = {{Bessey A and Chilcott J and Paisley S and Pandor A}}, note = {{Accessed on 2025/07/18}}}